Partner
CurrentAt Nixon Peabody, we see 21st century law as a tool to help shape our clients’ futures. We are constantly thinking about what is important to our clients now and next so we can foresee obstacles and opportunities in their space and smooth the way. We ensure they are equipped with winning legal strategies as they navigate the exciting and challenging times we live in. We work together to handle complex challenges in litigation, real estate, corporate law, intellectual property and finance… Show more At Nixon Peabody, we see 21st century law as a tool to help shape our clients’ futures. We are constantly thinking about what is important to our clients now and next so we can foresee obstacles and opportunities in their space and smooth the way. We ensure they are equipped with winning legal strategies as they navigate the exciting and challenging times we live in. We work together to handle complex challenges in litigation, real estate, corporate law, intellectual property and finance anywhere in the world.Recent Sample Experience:- Spherix Incorporated, as public company counsel on its $20 million follow-on registered direct securities offering; outside counsel on all 34 Act filings and general corporate legal advisor- Needham & Company, LLC and D.A. Davidson & Co. as underwriter’s counsel, for Radisys Corporation’s $23 million follow-on public offering of Common Stock- Cowen and Company, LLC as the exclusive Placement Agent for The Wet Seal, Inc.’s a $27 million follow-on Reg D Private Placement of public company securities- Tauriga Sciences, as public company counsel on its separate acquisitions of a (i) cleantech business line and its IP, and (ii) a wellness business and topical cream product line.- J.P. Morgan Securities, as underwriter’s counsel, in ARIAD Pharmaceuticals, Inc.’s $323 million public offering of common stock for newly FDA approved oncology therapy- Janney Montgomery Scott, as underwriter’s counsel, for d’ELia’s Inc.’s $15.8 million public offering of common stock, and a concurrent private placement of $21.8 million in principal amount of 7.25% convertible notes- Lazard Capital Markets LLC, Oppenheimer & Co. Inc., JMP Securities LLC and Maxim Group LLC, as underwriter’s counsel, for Organovo Holdings, Inc.’s $47 million public offering of common stock with over-allotment Show less
